Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome

被引:107
作者
Berneis, Kaspar
Rizzo, Manfredi
Lazzaroni, Veronica
Fruzzetti, Franca
Carmina, Enrico
机构
[1] Univ Palermo, Dept Clin Med & Emerging Dis, I-90139 Palermo, Italy
[2] Univ Zurich Hosp, Clin Endocrinol Diabet & Clin Nutr, CH-8091 Zurich, Switzerland
[3] Univ Pisa, Dept Obstet & Gynecol, I-56100 Pisa, Italy
基金
美国国家科学基金会; 美国国家航空航天局;
关键词
D O I
10.1210/jc.2006-1705
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: An altered lipid profile is common in polycystic ovary syndrome ( PCOS) and is usually characterized by increased triglycerides and low high-density lipoprotein (HDL)-cholesterol levels. In the general population, these alterations are often associated with the increase of small low-density lipoproteins ( LDLs) in the so-called "atherogenic lipoprotein phenotype" ( ALP) that determines a further increase of cardiovascular risk. In this study, we evaluated the presence of ALP in the plasma of women with PCOS. Setting: Measurements and analysis of LDL size were performed at the Clinic of Endocrinology, Diabetes, and Clinical Nutrition, University Hospital, Zurich. PCOS patients were recruited at the Department of Clinical Medicine, University of Palermo, and the Department of Obstetrics and Gynecology, University of Pisa. Patients: Thirty patients with PCOS ( hyperandrogenism and chronic anovulation) and 24 matched controls were studied. Anthropometric data, blood glucose, serum insulin lipid profile, and LDL size and subclasses were evaluated. Results: Compared with controls, patients with PCOS had higher plasma concentrations of insulin and triglycerides and lower HDL-cholesterol concentrations but no differences in LDL-cholesterol and total cholesterol. Patients with PCOS had smaller LDL size due to a reduction in LDL subclass I, with a concomitant increase in LDL subclasses III and IV. Fourteen PCOS patients had an increase of smaller LDL particles, and it represented the second most common lipid alteration after decrease in HDL- cholesterol. However, because in this PCOS population hypertriglyceridemia was only present in two patients, complete ALP was relatively uncommon. Conclusions: Increase of type III or type IV LDL subclasses is a common finding in PCOS and represents the second most common lipid alteration after HDL- cholesterol decrease. However, in our PCOS patients, because of relatively low triglyceride levels, complete ALP is uncommon.
引用
收藏
页码:186 / 189
页数:4
相关论文
共 31 条
[1]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2]   Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].
Apridonidze, T ;
Essah, PA ;
Iuorno, MJ ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :1929-1935
[3]   ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[4]   Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes [J].
Berneis, K ;
Jeanneret, C ;
Muser, E ;
Felix, B ;
Miserez, AR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (02) :227-234
[5]   Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS [J].
Carmina, E ;
Napoli, N ;
Longo, RA ;
Rini, GB ;
Lobo, RA .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (01) :141-145
[6]   Endothelial dysfunction in PCOS: Role of obesity and adipose hormones [J].
Carmina, E ;
Orio, F ;
Palomba, S ;
Longo, RA ;
Cascella, T ;
Colao, A ;
Lombardi, G ;
Rini, GB ;
Lobo, RA .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (04) :356.e1-356.e6
[7]   Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters [J].
Carmina, E ;
Chu, MC ;
Longo, RA ;
Rini, GB ;
Lobo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2545-2549
[8]   Polycystic ovary syndrome (PCOS): Arguably the most common endocrinopathy is associated with significant morbidity in women [J].
Carmina, E ;
Lobo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) :1897-1899
[9]   Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet [J].
Carmina, E ;
Legro, RS ;
Stamets, K ;
Lowell, J ;
Lobo, RA .
HUMAN REPRODUCTION, 2003, 18 (11) :2289-2293
[10]   Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome [J].
Christian, RC ;
Dumesic, DA ;
Behrenbeck, T ;
Oberg, AL ;
Sheedy, PF ;
Fitzpatrick, LA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) :2562-2568